Dr. Manpreet Singh Sabharwal, MD

Dr. Sabharwal practices at United Hospital in Saint Paul, Minnesota, part of Sutter Health.

Dr. Sabharwal's NPI, 1538472048, was assigned on July 26, 2010. Dr. Sabharwal holds Minnesota license 61192.

Dr. Sabharwal's primary practice is United Hospital, at 333 North Smith Avenue, Saint Paul, MN 55102 in Ramsey County. The practice phone is (763) 236-8205.

Dr. Sabharwal's primary practice is United Hospital in Saint Paul, Minnesota, part of Sutter Health. Dr. Sabharwal is also affiliated with St. Croix Regional Medical Center. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Sabharwal to 3 more hospitals, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabharwal practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sabharwal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Sabharwal's licenses on file in 2 states: Minnesota and Wisconsin.

CMS data shows 1,555 Medicare services from Dr. Sabharwal across 21 procedure codes in 2024, for 874 Medicare patients. Medicare paid $61,880 for them.

CMS counts 874 Medicare patients who saw Dr. Sabharwal in 2024. The largest group is 75 to 84, with 316 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sabharwal's median patient age at 74, with 45% women.

In 2024, Dr. Sabharwal wrote 5,324 Medicare Part D claims for 544 patients. 79% of them were for generic drugs. CMS names the drug for 5,197 of them, across 45 drugs with 11 or more claims each, at $2,192,770 in total drug cost. In 2023, CMS named 4,068 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sabharwal for performance year 2024, reported as part of a group. Dr. Sabharwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Sabharwal, published from 2011 to 2012. The most frequent topics are Chi-Square Distribution and Glomerular Filtration Rate. Dr. Sabharwal's most frequent co-authors are Emad F. Aziz, DO, MB, Narender Annapureddy, MD and Alexandre Miguel Benjo, MD.

CMS Open Payments shows 6 general payments to Dr. Sabharwal from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $449.